搜尋結果
How digital health companies are capitalizing on the GLP-1 boom
CNBC· 2 日前Novo Nordisk's blockbuster weight loss drug, which contains the second generation GLP-1 ...
Mounjaro And Zepbound Shortages Targeted With $5.3 Billion Eli Lilly Investment
Forbes· 3 日前... $5.3 billion into a new manufacturing site, boosting production for its weight ... ...
Weight-Loss Upstart Viking Needs a Deal to Vie With Lilly and Novo
Bloomberg· 5 日前Hope for a weight-loss drug that’s better than Ozempic and Wegovy has sent Viking Therapeutics ...
Lilly Invests $5.3 Billion to Boost Weight-Loss Drug Supply
Bloomberg· 3 日前Have a confidential tip for our reporters? Eli Lilly & Co. will spend $5.3 billion to boost ...
China Clears Eli Lilly’s Weight-Loss Drug, Only for Diabetes Now
Bloomberg· 6 日前Have a confidential tip for our reporters? China gave the greenlight to Eli Lilly & Co.’s ...
The Top 10 S&P 500 Stocks By Weight—A Boon Or Bane?
Forbes· 5 日前The S&P 500 index closed Tuesday’s trade at 5,321.41, setting a new all-time high, above the ...
This ETF aims to capture China's own 'Magnificent Seven'
CNBC· 4 日前"There's a lot of question marks about the Chinese economy and the potential for ...
5-minute listening: All about the ‘Fingerhakeln’ wrestling championship
South China Morning Post· 7 小時前3. Where did the finger wrestling competition take place? 5. When was the Fingerhakler Gau ...
Many Quit Weight-Loss Drugs Too Early for Benefits, Insurer Says
Bloomberg· 6 日前Nearly 60% of Americans who started taking weight-loss drugs between 2014 and 2023 didn’t ...
Ozempic Drug Semaglutide Could Protect Kidneys, Study Finds
Forbes· 2 日前Novo Nordisk’s weight loss injection semaglutide — the ingredient inside its wildly popular ...